It’s been a whirlwind year here at IPI, from antibody releases to workshops and lab expansion. In the past months, we released new recombinant antibodies targeting GPC1, GPC3 and GPC4 — but there’s plenty more to celebrate! In case you missed it, here’s an overview of everything that’s happened.
Protein releases
Last spring, we launched a set of 26 unique, functional anti-integrins. These marked our very first antibodies out to market! Next to hit the shelf — our epitope tag antibodies targeting V5, Protein C, DYKDDDDK, Rho, His, Biotin, EE, GCN4 and Strep tags. Further empowering researchers this fall, we released the plasmids encoding our epitope tag antibodies and our empty pTipi plasmid vector so researchers can make their proteins.
Education & events
Neuroscientists, protein scientists and technology developers joined us last June for our Lighting Up symposium. The day was filled with talks and posters focused on new imaging technologies and antibody discovery. We were thrilled to connect with our local scientific community.
We jumpstarted a series of antibody validation workshops, where researchers beta-tested IPI’s antibodies in development and shared research results. This community discussion allowed researchers to compare nuances in their experimental setups and allowed us to learn directly from the experts in these spaces. It’s a collaborative effort we’re thrilled to pilot, and we welcome new collaborators — email us for more information!
We traveled to Chicago to host our inaugural Antibodies Roadshow at the annual Society for Neuroscience meeting, a roving workshop convening scientists for roundtable discussions on neuroscience data and reagent antibody needs. This gathering yielded valuable insights into our neuroscience antibodies and connected us with new scientists worldwide.
Milestones
We’ve grown! We’re still on the Harvard campus, but now on two floors. This expansion will allow us more room for our burgeoning antibody discovery, production and research efforts. It provides us extra space to begin exploring future research areas beyond neuroscience, including cellular development and oncology.
Our antigen production team wrote a book chapter detailing their approach to cell surface receptor ectodomain screening. In January, senior scientist Anita Ghosh will present the work at the Cambridge Healthtech Institute’s annual Protein Science and Production Week, sharing the method with more researchers.
This year, we welcomed many new lab members, including several research associates and scientists. This growth expands our knowledge base in robotics design and hardware development, database curation, antibody discovery, chemical engineering, bioinformatics and computational biology, computer science and much more. We’re impressed by the expertise each individual brings to our team. To mark the moment, we gathered at a fall retreat to kick off cross-lab collaborations and platform innovations.
What’s next?
We’ve got big plans! We’re already busy producing new antibody collections, particularly for neurobiology targets. We’re building out protein science education programs, including short courses on yeast display technologies and lab automation. We continue to gather working groups to share research and evaluate IPI antibodies. And there’s much more to come.
Roll on, 2025!
